Mikubrel Sr (Metformin Hydrochloride)

Metformin Hydrochloride, the active ingredient in Mikubrel Sr, is a biguanide presented as an oral dosage form for oral use. It is used to improve blood glucose control in adults with type 2 diabetes mellitus.

GNH USA supplies Mikubrel Sr as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Hydrochloride is indicated for conditions affecting glucose metabolism and insulin sensitivity.

- Type 2 diabetes mellitus: improves glycaemic control and reduces HbA1c levels. - Prediabetes (high‑risk individuals): helps delay progression to overt diabetes. - Polycystic ovary syndrome: reduces insulin resistance and may improve ovulatory function.

Metformin Hydrochloride is associated with several adverse reactions.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhoea: frequent loose stools, especially at treatment initiation. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration in taste perception. - Weight loss: modest reduction in body weight. - Vitamin B12 deficiency: decreased absorption over long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic disturbance. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatic dysfunction: elevated liver enzymes. - Hypoglycaemia: when combined with other glucose‑lowering agents. - Anemia: due to reduced red blood cell production. - Electrolyte imbalance: especially with prolonged diarrhoea.

Metformin Hydrochloride requires careful monitoring and patient education.

- Renal function: assess eGFR before initiation and periodically thereafter. - Hepatic function: evaluate liver enzymes prior to treatment. - Heart failure: avoid in decompensated states due to lactic acidosis risk. - Vitamin B12 status: monitor levels during long‑term therapy. - Hypersensitivity: discontinue if allergic reactions occur. - Store at room temperature: keep in the original container, protect from moisture and heat.

Metformin Hydrochloride can interact with several medications, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: increase risk of lactic acidosis. - Alcohol: potentiates lactic acidosis. - Cimetidine: may raise metformin plasma concentrations. - Trimethoprim: can impair renal clearance of metformin. - Rifampicin: reduces metformin exposure.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - ACE inhibitors: monitor renal function and potassium. - Diuretics: assess for dehydration and renal impairment. - Other antidiabetic agents: adjust dosing to avoid hypoglycaemia. - Corticosteroids: may increase blood glucose, requiring dose adjustments.